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Abstract
Background: We evaluated the association of central versus overall adiposity on levels of thyroid stimulating hormone
(TSH), free triiodothyronine (fT3), and free thyroxine (fT4) among euthyroid subjects taken from a cross-sectional,
representative sample of the adult non-institutionalized U.S. population.
Methods: The National Health and Nutrition Examination Survey 2007–2008 included 1,623 men and 1,491 women who
were 20 years and older, with no history of thyroid or liver disease, kidney failure, diabetes, or thyroid function-altering
prescription medication use (based on self-report), and having TSH, fT3, and fT4 levels between 0.5–4.49 mIU/L, 2.5–3.9 pg/
mL, and 0.6–1.6 ng/dL, respectively. Associations between body mass index (BMI) and waist circumference (measures of
overall and central adiposity, respectively) and TSH, fT3, and fT4 levels were estimated using multivariable linear regression
models stratified by sex and adjusted for age, race, smoking status, and alcohol intake.
Results: An increase in serum TSH levels was observed for every 1-quartile increase in BMI in euthyroid men (3.8% [95% CI
0.8%, 6.8%]) and euthyroid women (4.0% [95% CI 1.6%, 6.5%]). Similar, albeit slightly weaker, associations were observed
with waist circumference. We also found increases in fT3 levels with every 1-quartile increase in BMI (1.0% in men and 1.3%
in women) and waist circumference (1.2% in men and 1.2% in women). No associations were observed with fT4.
Conclusions: Our results provide support that BMI and waist circumference are positively associated with levels of serum
TSH and f T3 but not fT4 among euthyroid adults. Longitudinal studies are needed to define the temporality of these
associations and their potential health implications.
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Introduction
The growing prevalence of overweight and obesity is becoming
an increasingly important health problem throughout the world
[1] as excess body weight is a known risk factor for mortality [2]
and a multitude of diseases, including diabetes [3,4], hypertension
[4], heart disease [4], ischemic stroke [5], and several types of
cancer [6]. While weight change is largely attributable to an
imbalance in energy intake and expenditure [1], it is also a well-
recognized and common manifestation of overt thyroid dysfunc-
tion due to regulation of resting energy expenditure (REE) by
thyroid hormones [7–8].
The potential mechanisms underlying the association between
body fat and thyroid function are less clear among euthyroid
individuals, in whom it is possible that weight change could
precede subsequent changes in thyroid hormone (triiodothyronine
[T3] and thyroxine [T4]) and thyroid stimulating hormone (TSH)
levels. Several cross-sectional studies have shown associations of
body fat with higher serum TSH [9–16] and T3 [17] and lower T4
[15,16,18,19] among euthyroid individuals, though there have
been some inconsistencies [12–14,17–20]. However, many of
these studies were limited due to small sample sizes (,500
participants) [13–15,17,20]; lack of adjustment for important
covariates associated with TSH, such as cigarette smoking [12–
15,20,21]; or only examined the relationship in special sub-groups
such as overweight or obese participants [14,17] or individuals
with a medical history of thyroid disease [20], which limits the
generalizability of the results. There is also conflicting evidence on
the association between central as opposed to overall adiposity and
TSH levels among euthyroid adults [13,17]. Thus, it remains
unclear whether hormonal and metabolic alterations common to
central adiposity (e.g., insulin resistance) may influence, or be
influenced by, thyroid status.
We investigated the association between body fatness, using
body mass index (BMI) and waist circumference as measures of
overall and central adiposity, respectively, and serum TSH, fT3,
and fT4 as measures of thyroid function among euthyroid adult
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e34979men and women using data from a nationally representative cross-
sectional study in the U.S., a population that includes a wide range
of body fatness as well as thyroid function.
Methods
Study population
The National Health and Nutrition Examination Survey
(NHANES) program began in 1960 as a series of cross-sectional
surveys of the U.S. civilian, non-institutionalized population
conducted for the purposes of obtaining nationally-representative
estimates of health and nutritional status. The program employs a
stratified, multistage probability sampling design with oversam-
pling of certain income, age, and race/ethnicity subgroups.
Beginning in 1999, surveys were released in 2-year cycles. The
data collection process for this survey has been previously
described in detail [22]. Study protocols for NHANES were
approved by the institutional review board at the National Center
for Health Statistics. All participants provided written informed
consent. Reports from NHANES indicate that the general U.S.
population is nutritionally iodine sufficient [23].
The eligible study population was restricted to 5,935 individuals
ages 20 and older who participated in NHANES 2007–2008. We
further excluded participants who were pregnant (n=57); had a
self-reported medical history of thyroid disease (n=552); reported
taking prescription medications that may influence thyroid
function (n=175); reported having a medical condition that may
influence thyroid function, including diabetes, kidney, and liver
disease (n=155); reported having general ‘‘poor health’’ (n=135);
had missing data on BMI (n=211), waist circumference (n=155),
levels of TSH (n=268) or free T3 or free T4 (n=3); or had
extreme values for BMI (,15 or .50 kg/m
2, n=17). We also
excluded participants with TSH, fT3, and fT4 outside the ranges of
0.5–4.49 mIU/L (n=282), 2.5–3.9 pg/mL (n=144), and 0.6–
1.6 ng/dL (n=55), respectively [24]. After these exclusions, a total
of 1,623 men and 1,491 women were eligible for this analysis.
Exposure assessment and classification
A team consisting of physicians, health and dietary interviewers,
and medical and health technicians conducted in-home interviews
and performed physical examinations from specially-designed and
equipped mobile centers. Interview items included age, sex,
education, race/ethnicity, pregnancy status, medical history of
thyroid disease (including thyroid cancer), use of prescription
medications, cigarette smoking, and alcohol intake. Interviewers
also obtained information on prescription medications from labels
on containers brought to the interview by the participants. Height,
weight, and waist circumference were measured in mobile
examination centers by trained health technicians using standard-
ized protocols and regularly-calibrated equipment. Waist circum-
ference was measured at minimal respiration with a flexible
anthropometric tape positioned parallel to the floor directly above
the iliac crest. Study staff previously reviewed and deleted unusual
or erroneous values from the 2007–2008 datasets.
Laboratory measurements
Participants who did not meet any of the exclusion criteria for
providing blood samples (i.e., hemophilia, recent recipient of
chemotherapy, certain medical symptoms) were eligible for thyroid
function assessment between 2007 and 2008, including the
measurement of TSH, fT3,f T 4, and thyroid autoantibodies.
Serum samples were analyzed for TSH (Access HYPERsensitive
human thyroid-stimulating hormone [hTSH] assay; Beckman
Coulter, Fullerton, CA), fT3 (Access free T3 assay; Beckman
Coulter, Fullerton, CA), fT4 (Access free T4 assay; Beckman
Coulter, Fullerton, CA), thyroperoxidase autoantibodies (TPOab;
Access TPO antibody assay, Beckman Coulter, Fullerton, CA),
and thyroglobulin antibodies (TgAb; Access thyroglobulin anti-
body assay, Beckman Coulter, Fullerton, CA) at the University of
Washington Medical Center, Department of Laboratory Medi-
cine, Immunology Division. The distribution of these measures in
the study population are shown in Table 1. The reference ranges
for TSH, fT3,f T 4, TPOab, TgAb were 0.34–5.60 mIU/L, 2.5–
3.9 pg/mL, 0.6–1.6 ng/dL, 0–9.0 IU/mL, and 0–4.0 IU/mL,
respectively [24]. Geometric means, medians, 25
th percentiles, and
75
th percentiles for these hormones, as well as thyroid autoanti-
bodies, among all adults (ages $20) prior to the study-specific
exclusions are shown in Table S1. Inter-assay coefficients of
variation ranged from 4.4–6.5%, 3.5–5.6%, 2.8–9.3%, 6.3–7.6%,
and 6.1–9.3% for TSH, fT3,f T 4, TPOab, and TgAb, respectively.
The quality control and quality assurance protocols used in
NHANES meet the 1988 Clinical Laboratory Improvement Act
standards.
Statistical methods
The complex, multistage, probability sampling survey design
data from NHANES 2007–2008 were analyzed using the survey
design commands in Stata version 9.2 (StataCorp, College Station,
TX). All descriptive statistics and regression analyses incorporated
the mobile examination center exam two-year sampling weights.
We examined the sex-specific associations of body fatness
measures (BMI and waist circumference; independent variables)
with TSH, fT3, and fT4 (dependent variables) using multivariable
linear regression, adjusting for age, race (non-Hispanic white, non-
Hispanic black, Hispanic, African American, other), smoking
status (never, former, current, missing), and alcohol intake (over
the past 12 months: none, 1 drink/day, 2 drinks/day, .2 drinks/
day, missing). In order to be directly comparable, the body fatness
measures were categorized into quartiles (see Table S2 for
quartile cutpoints), and these quartiles were modeled as contin-
uous variables. TSH, fT3, and fT4 concentrations were natural-log
transformed to more closely approximate normal distributions and
then back-transformed so that the beta coefficients from the
models represent a % increase in TSH, fT3,o rf T 4 for a 1-quartile
increase in the anthropometric variables. The shape of the dose-
response associations between BMI or waist circumference and
hormone concentrations were examined using restricted spline
models with knots corresponding to the 10
th,5 0
th, and 90
th
percentiles of the sex-specific BMI and waist circumference
distributions. Statistical significance for interactions between any
two factors was tested using the likelihood ratio test comparing a
model with the cross-product term to one without. All statistical
tests were two-sided, and a P-value of ,0.05 was considered
statistically significant.
Results
The mean age of both men and women in the study population
was 44 (range: 20–80). Men and women were predominantly non-
Hispanic white, never smokers, and light or non-drinkers, with a
mean BMI of 27.8 kg/m
2 (range: 15–50). The distributions of
BMI and waist circumference for men and women are shown in
Table S2. Geometric mean values for TSH, fT3 and fT4 in the
analytic population were 1.6 mIU/L, 3.2 pg/mL, and 0.8 ng/dL,
respectively.
Unadjusted for other factors, higher TSH levels were associated
with older ages, non-Hispanic white race/ethnicity, non-smoking,
moderate drinking, and higher BMI and waist circumference
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associated with younger ages, higher BMI and waist circumfer-
ence, current smoking, and heavier drinking. There was little
variation in fT4 across all of these characteristics.
After adjusting for age, race, smoking status, history of diabetes,
and alcohol intake, positive associations were observed between
BMI and serum TSH levels in men and women with increases in
TSH for each quartile increase in BMI of 3.8% (95% CI 0.8%,
6.8%; P-trend=0.02) and 4.0% (95% CI 1.6%, 6.5%; respective-
ly, P-trend=0.003) (Table 2). Age and smoking status did not
statistically significantly modify the association between BMI and
TSH in either men or women (data not shown). The associations
between TSH and waist circumference were similar compared to
the associations between TSH and BMI. For each quartile
increase in waist circumference, TSH increased by 3.1% (95% CI
0.6%, 5.6%; P-trend=0.02) in men and 3.6% (95% CI 1.2%,
6.0%; P-trend=0.01) in women (Table 2). Age and smoking
status did not significantly modify the waist-TSH association (data
not shown). The shape of the dose-response associations are shown
graphically in Figures S1 and S2.
BMI and waist circumference were significantly positively
associated with fT3 levels in men and women (Table 2). These
associations were of a weaker magnitude compared to the
associations for TSH. Every 1-quartile increase in BMI was
associated with a 1.0% increase in fT3 in men (P-trend=0.001)
and a 1.3% increase in fT3 in women (P-trend,0.001). Every 1-
quartile increase in waist circumference was associated with a
1.2% increase in men (P-trend,0.001) and 1.2% increase in
Table 1. Geometric means for TSH, fT3, and fT4 levels by select characteristics of male and female participants, NHANES 2007–
2008.
No. participants Hormone concentrations
TSH (mIU/L) fT3 (pg/mL) fT4 (ng/dL)
Sex
Men 1,623 1.58 3.26 0.77
Women 1,491 1.61 3.08 0.76
Age (years)
20–34 851 1.43 3.27 0.77
35–49 911 1.57 3.18 0.75
50–64 751 1.72 3.13 0.76
65–80 601 1.85 2.99 0.79
Race/ethnicity
Non-Hispanic white 1,487 1.66 3.16 0.76
Hispanic 925 1.49 3.28 0.77
Non-Hispanic black 565 1.30 3.13 0.75
Other 137 1.55 3.19 0.81
BMI (kg/m
2): WHO categories
a
15–18.4 (underweight) 49 1.59 3.13 0.80
18.5–24.9 (normal) 932 1.48 3.13 0.77
25–29.9 (overweight) 1,158 1.63 3.18 0.76
30–34.9 (obese class I) 598 1.69 3.21 0.76
35–50 (obese class II & III) 377 1.63 3.21 0.76
Waist circumference (cm)
,90 1,044 1.51 3.13 0.76
90–99 839 1.61 3.18 0.76
100–109 666 1.64 3.21 0.76
$110 565 1.69 3.22 0.76
Smoking status
b
Never 1,681 1.62 3.15 0.76
Former 733 1.66 3.14 0.76
Current 699 1.46 3.25 0.76
Alcohol intake (drinks/day)
b
None 1,085 1.61 3.15 0.77
1–2 1,061 1.65 3.13 0.76
.2 809 1.52 3.25 0.76
aWorld Health Organization classification of adult underweight, normal-weight, overweight, and obesity according to BMI [37].
bDoes not include missing values.
doi:10.1371/journal.pone.0034979.t001
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BMI was significantly stronger among never smokers compared to
ever smokers (P-interaction=0.04). No significant interactions
were observed for BMI or waist circumference by age (data not
shown). The shape of the dose-response associations are shown
graphically in Figures S3 and S4.
BMI and waist circumference were non-significantly inversely
associated with fT4 in men and women (Table 2). Age and
smoking status did not modify these associations (data not shown).
We observed no significant interactions between BMI and waist
circumference on levels of TSH, fT3,o rf T 4.
As a sensitivity analysis, we additionally restricted the analysis to
men and women within the normal range of thyroid autoanti-
bodies (TPOab,9 IU/mL and TgAb,4 IU/mL: n=1,502 men
and n=1,287 women) yielded similar results for fT3 and fT4. The
results for TSH were slightly weaker among women (per 1-quartile
increase in BMI: 3.2% increase; per 1-quartile increase in waist
circumference: 3.2% increase) but remained similar among men.
We also restricted the population to the subset with information
on fasting glucose levels (787 men and 722 women). We compared
the results before and after adjusting for fasting glucose, a potential
mediator of the relationship between body fat and thyroid
function. Although we generally observed positive associations
between fasting glucose and TSH and fT3 levels, associations for
BMI and waist circumference with TSH and fT3 adjusted for
fasting glucose were very similar to results unadjusted for fasting
glucose, suggesting that the positive associations observed between
BMI and waist circumference and TSH and fT3 is not completely
mediated by insulin resistance.
Discussion
In this study of euthyroid men and women taken from a large,
nationally-representative sample of the civilian, non-institutional-
ized U.S. population, we observed statistically significant positive
associations of serum TSH and, to a lesser degree, fT3 with both
BMI and waist circumference. The magnitudes of the associations
were generally similar between men and women. We found no
association between BMI or waist circumference and fT4 levels. In
comparing our results to only those other studies that had large
sample sizes, adjusted for known confounders (e.g., smoking), and
were not restricted to overweight or obese participants or
individuals with a medical history of thyroid disease [9–
11,16,18,19], our finding of a positive association between BMI
and TSH is consistent with all but two studies, one of healthy
women participating in a primary health screening in Korea [18]
and one of adults from rural Western Australia [19].
The basis for the relationship between body fatness and thyroid
hormone levels is obscured by the lack of understanding regarding
its temporality. In overt hypothyroidism, decreased thyroid
hormone actions, particularly those of T3, lead to weight gain
through reduced basal metabolic rate and decreased physical
activity [8]. However, in the euthyroid range of thyroid status, it is
unclear whether changes in markers of thyroid function precede
changes in weight, or vice versa. Our finding of a positive
association of both BMI and waist circumference with TSH and
fT3 levels is not completely consistent with an influence of thyroid
hormones on resting energy expenditure within the euthyroid
range. One way in which weight gain could lead to an increase in
serum TSH levels and, subsequently, thyroid hormone levels, is
through the stimulatory effect of leptin, an adipose tissue-derived
hormone, on thyrotropin-releasing hormone (TRH) [25–27] or by
decreasing thyroid hormone resistance [8]. Other adipokines, such
as interleukin-6 and tumor necrosis factor-a, have been suggested
to play a role, but their relation to thyroid function remains poorly
understood [28]. FT3 levels are elevated in obesity to increase
resting energy expenditure and prevent additional fat accumula-
tion [8]; thus our finding of a positive association between BMI
and waist circumference with fT3 may be the result of recent
weight gain at the time of blood draw leading to an increase in fT3
levels. Interestingly, the same positive association was not observed
for fT4. One explanation is that the divergent associations for fT3
and fT4 reflect an increased deiodinase activity in obesity [29].
The positive associations for both TSH and fT3 and slightly
inverse association for fT4, therefore, may reflect mechanisms
whereby body fat influences thyroid hormone levels within the
euthyroid range.
The major strengths of this study were its large size, which
allowed for relatively precise evaluation of the associations of
interest, and the survey design, in which participants were sampled
to be representative of the entire non-institutionalized U.S.
population, possibly yielding more widely representative results
than that of many previous studies on this topic. Due to the cross-
Table 2. Association of BMI and waist circumference with natural logarithm-transformed hormone concentrations, NHANES 2007–
2008.
Men Women
% increase
a
P-trend % increase
a
P-trend
No. participants n=1,623 n=1,491
TSH (mIU/L)
BMI (per quartile increase) 3.8 (0.8, 6.8) 0.02 4.0 (1.6, 6.5) 0.003
Waist (per quartile increase) 3.1 (0.6, 5.6) 0.02 3.6 (1.2, 6.0) 0.01
fT3 (pg/mL)
BMI (per quartile increase) 1.0 (0.5, 1.5) 0.001 1.3 (0.7, 1.8) ,0.001
Waist (per quartile increase) 1.2 (0.8, 1.7) ,0.001 1.2 (0.6, 1.8) ,0.001
fT4 (ng/dL)
BMI (per quartile increase) 20.5 (21.2, 0.3) 0.21 20.7 (21.6, 0.3) 0.14
Waist (per quartile increase) 20.4 (21.5, 0.6) 0.40 20.6 (21.5, 0.3) 0.19
aAdjusted for age, race, smoking status, and alcohol intake.
doi:10.1371/journal.pone.0034979.t002
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assess the timing of the association between the accumulation of
body fat and variation in TSH, fT3,o rf T 4 levels. We also lacked
data on serum leptin concentrations to directly assess its role in the
body fat-TSH association. Waist circumference, which is more
strongly predictive of insulin resistance, diabetes, and other
cardiometabolic abnormalities compared to BMI [30–32], was
generally slightly less strongly associated with TSH compared to
BMI, suggesting that insulin resistance is unlikely to account for
the associations we observed between body fatness and TSH; this
was supported by the finding that adjusting for fasting glucose
levels in the subset of the population with this information did not
attenuate any of the results. However, neither BMI nor waist
circumference can distinguish visceral from subcutaneous adipose
tissue in the abdomen, which show clear differences with regard to
metabolic and lipolytic activity and insulin sensitivity [33].
Thyroid function may need to be evaluated in relation to more
accurate measures of visceral and subcutaneous adipose tissue to
further understand the biological mechanisms underlying the
positive associations between overall and central adiposity and
TSH and fT3 observed in this and other studies.
In summary, we found that measures of overall and central
adiposity were associated with higher circulating levels of TSH
and fT3 in euthyroid adults. We observed no association with fT4
levels. Although weight loss and weight gain are well-known
consequences of overt thyroid dysfunction, our results suggest that,
within the euthyroid range, excess body weight may induce
changes in thyroid hormone levels. Experimental and/or longitu-
dinal studies are needed to assess whether weight loss or
maintenance among individuals who are euthyroid may help to
prevent the development of subclinical or overt hypothyroidism
and associated health risks [34–36].
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